Kristopher M. Kirmess

Tau Kinetics in Neurons and the Human Central Nervous System

Chihiro Sato, Nicolas R. Barthélemy, Kwasi G. Mawuenyega et al. · Neuron · 2018 · 573 citations · Full text

Neurodynamics, Neurophysiology, Synaptic Transmission +9

Characterization of pre‐analytical sample handling effects on a panel of Alzheimer's disease–related blood‐based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group

Inge M.W. Verberk, Els O. Misdorp, Jannet Koelewijn et al. · Alzheimer s & Dementia · 2021 · 222 citations · Full text

A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis

Tim West, Kristopher M. Kirmess, Matthew R. Meyer et al. · Molecular Neurodegeneration · 2021 · 220 citations · Full text

Effect of Race on Prediction of Brain Amyloidosis by Plasma Aβ42/Aβ40, Phosphorylated Tau, and Neurofilament Light

Suzanne E. Schindler, Thomas K. Karikari, Nicholas J. Ashton et al. · Neurology · 2022 · 140 citations · Full text

The PrecivityAD™ test: Accurate and reliable LC-MS/MS assays for quantifying plasma amyloid beta 40 and 42 and apolipoprotein E proteotype for the assessment of brain amyloidosis

Kristopher M. Kirmess, Matthew R. Meyer, Mary S. Holubasch et al. · Clinica Chimica Acta · 2021 · 129 citations · Full text